100 Years of Drug Delivery to the Lungs.
Sign Up to like & getrecommendations! Published in 2019 at "Handbook of experimental pharmacology"
DOI: 10.1007/164_2019_335
Abstract: Inhalation therapy is one of the oldest approaches to the therapy of diseases of the respiratory tract. It is well recognised today that the most effective and safe means of treating the lungs is to… read more here.
Keywords: years drug; drug delivery; delivery lungs; delivery ... See more keywords
Informing and Empowering Patients and Clinicians to Make Evidence-Supported Outcome-Based Decisions in Relation to SGLT2 Inhibitor Therapies: The Use of the Novel Years of Drug administration (YoDa) Concept
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-021-01105-7
Abstract: The American Diabetes Association guidelines for the management of type 2 diabetes mellitus recommends treating patients with atherosclerotic cardiovascular diseases, heart failure or diabetic kidney disease with sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists,… read more here.
Keywords: drug; inhibitor; evidence; drug administration ... See more keywords
IMPACT OF NEOATHEROSCLEROSIS OBSERVED AT MORE THAN 3 YEARS AFTER DRUG-ELUTING STENT IMPLANTATION ON SUBSEQUENT ADVERSE EVENTS
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)31916-8
Abstract: Although the clinical impact of neoatherosclesis (NA) at 1 year has been reported, that of NA at later phase is not completely elucidated. This study sought to investigate the association between OCT findings at very… read more here.
Keywords: impact neoatherosclerosis; years drug; drug eluting; drug ... See more keywords